Symbyax (Olanzapine and Fluoxetine) for Depression
Overview Symbyax is approved by the U.S. Food and Drug Administration (FDA) for the treatment of acute depressive episodes associated with bipolar I disorder and for treatment-resistant depression (depression that has not…